Literature DB >> 10570417

Computerized nuclear morphometry is a useful technique for evaluating the high metastatic potential of colorectal adenocarcinoma.

M Ikeguchi1, T Sakatani, K Endo, M Makino, N Kaibara.   

Abstract

BACKGROUND: Nuclear profiles have been reported to be useful prognostic predictors in various cancers. Data from computerized morphometry are objective and are quickly obtained by conventional microscopic analysis. However, this image analysis of nuclear features has been only rarely applied to investigations of colorectal adenocarcinoma. The aim of this study was to evaluate the correlation between the morphologic nuclear features and clinicopathologic parameters in cases of colorectal adenocarcinoma.
METHODS: Morphometric nuclear features (nuclear area, perimeter, and shape) were analyzed in 343 patients with colorectal carcinoma and in 57 patients with colorectal adenoma. In each case, 300 nuclei of carcinoma or adenoma cells were analyzed on routine hematoxylin and eosin stained slides by means of a computer-assisted image analysis system that involved tracing the nuclear profiles (magnification x400) on a computer monitor. The morphometric data were compared with patients' survival, clinicopathologic status, and DNA ploidy pattern of tumors.
RESULTS: The mean nuclear area (NA) enlarged from normal colorectal mucosa to adenoma and carcinoma (normal mucosa: n = 343, mean NA = 19 micrometer(2); adenoma: n = 57, mean NA = 34 micrometer(2); mucosal carcinoma: n = 15, mean NA = 45 micrometer(2); P < 0.001). In 343 colorectal carcinomas, NAs of cancer cells in tumors with lymphatic invasion, venous invasion, lymph node metastasis, or hepatic metastasis were significantly larger than those of cancer cells in tumors without such factors. The mean NA of DNA aneuploid tumors was larger than that of DNA diploid tumors (P < 0.001). The nuclear area of cancer cells was determined to be one of the independent prognostic factors in multivariate analysis (P < 0.001). Moreover, the large nuclear area of cancer cells was recognized as one of the risk factors of metachronous hematogenic metastasis in patients after curative surgery.
CONCLUSIONS: Data from computerized morphometry are objective and can be obtained rapidly by conventional microscopic analysis. The nuclear area of cancer cells appears to predict 1) the ability of cancer cells to invade the microvessels in the colorectal wall and 2) the ability of cancer cells to metastasize to the lymph nodes or liver. Therefore, nuclear morphometry is beneficial in mass screening to select patients who are at risk of hematogenic or lymph node metastatic recurrence after curative surgery for colorectal carcinoma. Copyright 1999 American Cancer Society.

Entities:  

Mesh:

Year:  1999        PMID: 10570417     DOI: 10.1002/(sici)1097-0142(19991115)86:10<1944::aid-cncr10>3.0.co;2-2

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

1.  Nuclear shape descriptors by automated morphometry may distinguish aggressive variants of squamous cell carcinoma from relatively benign skin proliferative lesions: a pilot study.

Authors:  Weixi Yang; Rong Tian; Tongqing Xue
Journal:  Tumour Biol       Date:  2015-03-10

2.  Follicular-derived neoplasms: morphometric and genetic differences.

Authors:  A Proietti; C Sartori; N Borrelli; R Giannini; G Materazzi; P Leocata; R Elisei; P Vitti; P Miccoli; F Basolo
Journal:  J Endocrinol Invest       Date:  2013-07-23       Impact factor: 4.256

3.  A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma.

Authors:  Kyuichi Kadota; Kei Suzuki; Stefan S Kachala; Emily C Zabor; Camelia S Sima; Andre L Moreira; Akihiko Yoshizawa; Gregory J Riely; Valerie W Rusch; Prasad S Adusumilli; William D Travis
Journal:  Mod Pathol       Date:  2012-04-13       Impact factor: 7.842

4.  Association between Nuclear Morphometry Parameters and Gleason Grade in Patients with Prostatic Cancer.

Authors:  Kamil Malshy; Gilad E Amiel; Dov Hershkovitz; Edmond Sabo; Azik Hoffman
Journal:  Diagnostics (Basel)       Date:  2022-05-31

5.  Dysplasia discrimination in intestinal-type neoplasia of the esophagus and colon via digital image analysis.

Authors:  David R Martin; David R Braxton; Alton B Farris
Journal:  Virchows Arch       Date:  2016-08-05       Impact factor: 4.064

Review 6.  Stage-specific frequency and prognostic significance of aneuploidy in patients with sporadic colorectal cancer--a meta-analysis and current overview.

Authors:  Tilman Laubert; Sandra Freitag-Wolf; Michael Linnebacher; Alexandra König; Brigitte Vollmar; Jens K Habermann
Journal:  Int J Colorectal Dis       Date:  2015-06-09       Impact factor: 2.571

7.  High-Content Image-Based Single-Cell Phenotypic Analysis for the Testicular Toxicity Prediction Induced by Bisphenol A and Its Analogs Bisphenol S, Bisphenol AF, and Tetrabromobisphenol A in a Three-Dimensional Testicular Cell Co-culture Model.

Authors:  Lei Yin; Jacob Steven Siracusa; Emily Measel; Xueling Guan; Clayton Edenfield; Shenxuan Liang; Xiaozhong Yu
Journal:  Toxicol Sci       Date:  2020-02-01       Impact factor: 4.849

8.  Metachronous metastasis- and survival-analysis show prognostic importance of lymphadenectomy for colon carcinomas.

Authors:  Tilman Laubert; Jens K Habermann; Claudia Hemmelmann; Markus Kleemann; Elisabeth Oevermann; Ralf Bouchard; Philipp Hildebrand; Thomas Jungbluth; Conny Bürk; Hamed Esnaashari; Erik Schlöricke; Martin Hoffmann; Andreas Ziegler; Hans-Peter Bruch; Uwe J Roblick
Journal:  BMC Gastroenterol       Date:  2012-03-23       Impact factor: 3.067

9.  Morphology to morphometry in cytological evaluation of thyroid lesions.

Authors:  S Shanmuga Priya; Sandhya Sundaram
Journal:  J Cytol       Date:  2011-07       Impact factor: 1.000

10.  Expression of PPARdelta in multistage carcinogenesis of the colorectum: implications of malignant cancer morphology.

Authors:  O Takayama; H Yamamoto; B Damdinsuren; Y Sugita; C Y Ngan; X Xu; T Tsujino; I Takemasa; M Ikeda; M Sekimoto; N Matsuura; M Monden
Journal:  Br J Cancer       Date:  2006-09-12       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.